Regeneron Pharmaceuticals on Monday said it would buy genetic testing company 23andMe, which filed for bankruptcy in March ...

Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing ...

Some 300 pharmaceutical manufacturing jobs are to be created over three years in Limerick, Ireland, by Regeneron, the New York-based specialist in biopharmaceuticals. The Raheen Business Park in ...